Nisa Investment Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666 | Sell |
141
-179
| -56% | -$845 | ﹤0.01% | 2822 |
|
|
2025
Q1 | $1.47K | Sell |
320
-11
| -3% | -$50 | ﹤0.01% | 2540 |
|
|
2024
Q4 | $1.59K | Buy |
331
+209
| +171% | +$1K | ﹤0.01% | 2562 |
|
|
2024
Q3 | $572 | Sell |
122
-110
| -47% | -$516 | ﹤0.01% | 2700 |
|
|
2024
Q2 | $1.31K | Buy |
+232
| New | +$1.31K | ﹤0.01% | 2456 |
|
|
2024
Q1 | – | Sell |
-30
| Closed | -$127 | – | 2820 |
|
|
2023
Q4 | $127 | Buy |
+30
| New | +$127 | ﹤0.01% | 2601 |
|
|
2023
Q3 | – | Sell |
-3,373
| Closed | -$22.2K | – | 2842 |
|
|
2023
Q2 | $22.2K | Buy |
3,373
+3,210
| +1,969% | +$21.2K | ﹤0.01% | 2061 |
|
|
2023
Q1 | $1K | Buy |
+163
| New | +$1K | ﹤0.01% | 2477 |
|
|
2022
Q2 | – | Sell |
-8,540
| Closed | -$97K | – | 2516 |
|
|
2022
Q1 | $97K | Buy |
8,540
+4,900
| +135% | +$55.7K | ﹤0.01% | 1626 |
|
|
2021
Q4 | $55K | Sell |
3,640
-1,260
| -26% | -$19K | ﹤0.01% | 1711 |
|
|
2021
Q3 | $84 | Hold |
4,900
| – | – | ﹤0.01% | 1778 |
|
|
2021
Q2 | $105 | Buy |
4,900
+200
| +4% | +$4 | ﹤0.01% | 1671 |
|
|
2021
Q1 | $71 | Hold |
4,700
| – | – | ﹤0.01% | 1893 |
|
|
2020
Q4 | $62K | Buy |
+4,700
| New | +$62K | ﹤0.01% | 1930 |
|